CaginiCDi PasqualeGLupidiMTimolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery. Eur J Ophthalmol. 2014;24:857–61.
2.
RoulandJFMorel-MandrinoPElenaPPPolzerHSunder Raj P. Timolol 0.1% gel (Nyogel 0.1% once daily versus conventional timolol 0.5% solution twice daily: a comparison of efficacy and safety. Ophthalmologica. 2002;216:449–54.
3.
QuarantaLKatsanosAFlorianiIRivaIRussoAKonstasAGCircadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma. J Clin Pharmacol. 2012;52:1552–7.
4.
UusitaloHNiñoJTahvanainenKEfficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Acta Ophthalmol Scand. 2005;83:723–8.
5.
UusitaloHKähönenMRopoAImproved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244:1491–6.
6.
PouliquenPLes gels de carbomère dans le traitement de l'oeil sec. J Fr Ophtalmol. 1999;22:903–13.
7.
WilsonCGZhuYPFrierMRaoLSGilchristPPerkinsACOcular contact time of a carbomer gel (GelTears) in humans. Br J Ophthalmol. 1998;82:1131–4.
8.
RolleTCurtoDAlovisiCFranzoneMBrogliattiBGrignoloFMTimogel® vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance. Eur J Ophthalmol. 2012;22:28–33.
9.
FrezzottiPFogagnoloPHakaGIn vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. Acta Ophthalmol. 201492:e133–40.
10.
LaurenceJHolderDVogelRA double-masked, placebo-controlled evaluation of timolol in a gel vehicle. J Glaucoma. 1993;2:177–82.
